Christopher B Ehrlich

CIK 1293973 · Chairman and CEO · last filed 2026-01-09

Christopher B Ehrlich is a Chairman and CEO who has filed 37 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for PBAXW, was dated Jan 9, 2026. Across all open-market trades the lifetime net is +$8.1M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

37

Lifetime Open-Market Net

$8.09M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Chairman and CEO 5,795,408 $0.05 $290.3K $0 8 2026-01-09
eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Director 177,381 $0.00 $106 $90.7K 13 2024-06-13
CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted CEO and Secretary 699,996 $10.37 $7.26M $0 1 2021-10-12
LWACU See Remarks $10.30 $0 1 2021-01-14
BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Director 6,846 $8.00M 5 2009-04-08

Recent Filings

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-09 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) $0 EDGAR
2025-06-02 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) $0 EDGAR
2025-03-06 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) $0 EDGAR
2025-02-26 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) $0 EDGAR
2024-12-04 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) $0 EDGAR
2024-10-02 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Mixed +5,312,983 $0 EDGAR
2024-06-13 eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Grant (A) $0 EDGAR
2024-03-27 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) $0 EDGAR
2024-02-21 eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Grant (A) $0 EDGAR
2024-02-16 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Mixed −4,813,821 $0 EDGAR
Showing 110 of 37
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.